Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference

Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening
Night of TEDMED Conference
Hundreds of Thousands of Patients Already Treated Worldwide

CANTON, Mass. and SAN DIEGO, Oct. 27 /PRNewswire/ -- Organogenesis, Inc. Chief
Medical Officer Dr. Damien Bates will speak on the first night of the
prestigious TEDMED medical innovation conference beginning today in San Diego,
Calif. Dr. Bates' speech "Where Does Replacement Skin Come From?" will outline
developments in the emerging and promising field of Regenerative Medicine and
discuss the transformation of patient lives.

The field of regenerative medicine has now reached the stage of translating
groundbreaking science into viable product offerings. Organogenesis was the
first company to successfully commercialize and mass produce living
regenerative medicine products - reaching hundreds of thousands of patients in
the U.S. and around the world. Its flagship product, Apligraf®, was the first
regenerative medicine product to have received U.S. Food and Drug
Administration (FDA) approvals to close both diabetic foot ulcers and venous
leg ulcers.

Damien Bates, MD, PhD, FRACS (Plast.), is a practicing board certified plastic
and reconstructive surgeon with over 12 years of clinical experience in both
the U.S. and Australia. Dr. Bates holds an MD from the University of Sydney
and a PhD in developmental biology from the University of Melbourne.

About TEDMED
The fifth in a series created by Marc Hodosh and Richard Saul Wurman, TEDMED
celebrates conversations that demonstrate the intersection and connections
between all things medical and healthcare related: from personal health to
public health, devices to design and Hollywood to the hospital. Together, this
encompasses more than twenty percent of America's GNP while touching
everyone's life around the globe. TEDMED 2009 will take place October 27-30
in San Diego, Calif. For more information, visit www.tedmed.com.

About Regenerative Medicine
A new frontier in healthcare, regenerative medicine utilizes living human
cells to repair or replace body tissue damaged by injury, disease or even the
natural aging process. Regenerative medicine is a multidisciplinary field
which brings together biology, medicine, and engineering to empower scientists
to grow living cells, tissues and organs in the laboratory, and to safely
implant them into the human body for the purposes of healing.

About Organogenesis, Inc.
Having pioneered the field, Massachusetts based Organogenesis, Inc. is a world
leading regenerative medicine company focused in the areas of bio-active wound
healing, oral regeneration and bio-surgery. The company's mission is to bring
the medical marvel of regenerative medicine products to patients and to
standardize their use in everyday medical care. For more information, visit
www.organogenesis.com.

SOURCE Organogenesis, Inc.

Angelyn Lowe, +1-858-273-1805, alowe@chasepr.com, for Organogenesis, Inc.